• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

P53

  • Lamassu Biotech Receives FDA Approval to Initiate Clinical Trials for Innovative Cancer Treatment
    April 23, 2024

    Lamassu Biotech Receives FDA Approval to Initiate Clinical Trials for Innovative Cancer Treatment

    Charles H. Weaver, MD
  • Xpovio (selinexor) in Endometrial Cancer
    September 22, 2023

    Xpovio (selinexor) in Endometrial Cancer

    Charles H. Weaver, MD
  • Targeting p53 Tumor Suppressor Genes in Cancer
    November 15, 2020

    Targeting p53 Tumor Suppressor Genes in Cancer

    Charles H. Weaver, MD
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...